{"epoch": 0, "debates": [{"topic": {"id": "topic_1", "title": "Healthcare Reform", "description": "Should the government implement universal healthcare?"}, "statements": [{"type": "mediator", "mediator_id": "mediator_1", "statement": "Good evening, and welcome. Tonight, we delve into the complex world of healthcare reform, specifically exploring the potential impacts of universal healthcare. Our focus tonight is a critical aspect of this debate: How might universal healthcare affect innovation within the pharmaceutical and medical device industries?"}, {"type": "candidate", "candidate_id": "candidate_1", "candidate_name": "Alice Johnson", "statement": "The claim that universal healthcare stifles innovation in pharmaceuticals and medical devices is a scare tactic. We can negotiate fair drug prices, as other developed nations do, and still incentivize innovation through research grants and public-private partnerships. My belief is that by ensuring everyone has access to care, we'll actually *boost* innovation, as more people can participate in clinical trials and benefit from new treatments."}, {"type": "candidate", "candidate_id": "candidate_2", "candidate_name": "Bob Smith", "statement": "Alice's proposal to negotiate drug prices ignores the reality that innovation thrives on the promise of returns. Government price controls would inevitably decrease investment in research and development, leading to fewer new treatments and devices. Instead, let's foster competition and transparency in the market to drive down costs and encourage innovation."}]}], "newsfeed": {"posts": [{"id": "84ddaebb-6219-498d-9eed-c20133103c6b", "persona_id": "persona_2", "content": 